These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30894497)

  • 21. Potential therapeutic targets for steroid-resistant asthma.
    Wang W; Li JJ; Foster PS; Hansbro PM; Yang M
    Curr Drug Targets; 2010 Aug; 11(8):957-70. PubMed ID: 20412045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma.
    Umland SP; Schleimer RP; Johnston SL
    Pulm Pharmacol Ther; 2002; 15(1):35-50. PubMed ID: 11969362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid receptor isoforms in steroid-dependent asthma.
    Jakieła B; Bochenek G; Sanak M
    Pol Arch Med Wewn; 2010 Jun; 120(6):214-22. PubMed ID: 20567205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity.
    Li JJ; Tay HL; Maltby S; Xiang Y; Eyers F; Hatchwell L; Zhou H; Toop HD; Morris JC; Nair P; Mattes J; Foster PS; Yang M
    J Allergy Clin Immunol; 2015 Aug; 136(2):462-73. PubMed ID: 25772595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why do some asthma patients respond poorly to glucocorticoid therapy?
    Henderson I; Caiazzo E; McSharry C; Guzik TJ; Maffia P
    Pharmacol Res; 2020 Oct; 160():105189. PubMed ID: 32911071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled glucocorticoid treatment prevents the response of CD8
    Zuśka-Prot M; Maślanka T
    Int Immunopharmacol; 2017 Dec; 53():63-72. PubMed ID: 29040944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel glucocorticoid receptor agonists in the treatment of asthma.
    Cazzola M; Coppola A; Rogliani P; Matera MG
    Expert Opin Investig Drugs; 2015; 24(11):1473-82. PubMed ID: 26293110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical considerations in the use of inhaled corticosteroids for asthma.
    Williams DM
    Pharmacotherapy; 2001 Mar; 21(3 Pt 2):38S-48S. PubMed ID: 11253867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthma.
    Calzetta L; Rinaldi B; Cazzola M; Matera MG
    Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):813-22. PubMed ID: 27253498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of glucocorticoids on lymphocyte activation in patients with steroid-sensitive and steroid-resistant asthma.
    Spahn JD; Landwehr LP; Nimmagadda S; Surs W; Leung DY; Szefler SJ
    J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1073-9. PubMed ID: 8977508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid Receptor Nuclear Translocation in CD4 T Cells from Severe and Moderate Asthmatic Patients Treated with Fluticasone/Vilanterol.
    Alizadeh Z; Mazinani M; Mortaz E; Fazlollahi MR; Adcock I; Moein M
    Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):1-8. PubMed ID: 29512364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated Allergen Exposure in A/J Mice Causes Steroid-Insensitive Asthma via a Defect in Glucocorticoid Receptor Bioavailability.
    Serra MF; Cotias AC; Pão CRR; Daleprane JB; Jurgilas PB; Couto GC; Anjos-Valotta EA; Cordeiro RSB; Carvalho VF; Silva PMR; Martins MA
    J Immunol; 2018 Aug; 201(3):851-860. PubMed ID: 29914889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid-resistant asthma: evaluation and management.
    Nimmagadda SR; Spahn JD; Leung DY; Szefler SJ
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):345-55; quiz 355-6. PubMed ID: 8933772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticosteroid resistance in asthma: Cellular and molecular mechanisms.
    Caramori G; Nucera F; Mumby S; Lo Bello F; Adcock IM
    Mol Aspects Med; 2022 Jun; 85():100969. PubMed ID: 34090658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.
    Adcock IM; Lane SJ; Brown CR; Lee TH; Barnes PJ
    J Exp Med; 1995 Dec; 182(6):1951-8. PubMed ID: 7500041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of glucocorticoids in the management of asthma.
    Spahn JD; Leung DY
    Allergy Asthma Proc; 1996; 17(6):341-50. PubMed ID: 8993728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased glucocorticoid binding affinity to glucocorticoid receptor is important in the poor response to steroid therapy of older-aged patients with severe bronchial asthma.
    Cho YJ; Lee KE
    Allergy Asthma Proc; 2003; 24(5):353-8. PubMed ID: 14619336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and management of steroid-resistant asthma.
    Leung DY; Szefler SJ
    Clin Chest Med; 1997 Sep; 18(3):611-25. PubMed ID: 9329880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocortiosteroid subsensitivity and asthma severity.
    Mukherjee M; Svenningsen S; Nair P
    Curr Opin Pulm Med; 2017 Jan; 23(1):78-88. PubMed ID: 27801710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoids attenuate acute graft-versus-host disease by suppressing the cytotoxic capacity of CD8(+) T cells.
    Theiss-Suennemann J; Jörß K; Messmann JJ; Reichardt SD; Montes-Cobos E; Lühder F; Tuckermann JP; AWolff H; Dressel R; Gröne HJ; Strauß G; Reichardt HM
    J Pathol; 2015 Mar; 235(4):646-55. PubMed ID: 25358639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.